Main menu

Rapid ultra-high enrichment of bacterial pathogens at low concentration from whole blood for species ID and AMR prediction using Oxford Nanopore sequencing


There is an urgent need for rapid and accurate diagnostics to guide targeted therapy for blood stream infections (BSIs). BSIs are among the leading causes of morbidity and mortality, yet the status quo culture-based diagnostics have a multi-day turnaround time (TAT) and limited ability to guide antibiotic therapy. Day Zero Diagnostics has developed Blood2Bac™, a species-agnostic culture-free method to enrich bacterial DNA directly from whole blood samples by a factor of 100,000,000. When Blood2Bac is coupled with ONT rapid whole genome sequencing and Day Zero Diagnostics’ algorithmic tools, we can determine bacterial species identification (ID) and antimicrobial resistance (AMR) within 10 hours of blood draw, a drastic decrease in diagnostic TAT. Here we demonstrate the performance of our technology on both contrived (spike-in) samples and clinical samples.

Download the PDF

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag